These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2432110)

  • 1. Accumulation of hydroxyethyl starch (HES) in the liver of patients with renal failure and portal hypertension.
    Dienes HP; Gerharz CD; Wagner R; Weber M; John HD
    J Hepatol; 1986; 3(2):223-7. PubMed ID: 2432110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Ascites as a complication of hepatic storage of hydroxyethyl starch in long-term dialysis].
    Pfeifer U; Kult J; Förster H
    Klin Wochenschr; 1984 Sep; 62(18):862-6. PubMed ID: 6208407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Worsening of hepatic dysfunction as a consequence of repeated hydroxyethylstarch infusions.
    Christidis C; Mal F; Ramos J; Senejoux A; Callard P; Navarro R; Trinchet JC; Larrey D; Beaugrand M; Guettier C
    J Hepatol; 2001 Dec; 35(6):726-32. PubMed ID: 11738099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydroxyethylstarch solutions versus saline for the treatment of intradialytic hypotension.
    Konings M; Wolters E; Betjes MG
    J Ren Care; 2007; 33(3):130-3. PubMed ID: 19160885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anaphylactoid reactions due to hydroxyethyl starch infusion.
    Ring J; Seifert J; Messmer K; Brendel W
    Eur Surg Res; 1976; 8(5):389-99. PubMed ID: 62664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue deposits of hydroxyethyl starch (HES): dose-dependent and time-related.
    Sirtl C; Laubenthal H; Zumtobel V; Kraft D; Jurecka W
    Br J Anaesth; 1999 Apr; 82(4):510-5. PubMed ID: 10472213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Intravascular persistence, tissue storage and excretion of hydroxyethyl starch (HAS)].
    Thompson WL; Fukushima T; Rutherford RB; Walton RP
    Infusionsther Klin Ernahr; 1979 Jun; 6(3):151-5. PubMed ID: 88413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravascular persistence of hydroxyethyl starch (HES) after serial granulocyte collections using HES in man.
    Ring J; Sharkoff D; Richter W
    Vox Sang; 1980 Oct; 39(4):181-5. PubMed ID: 6163255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pharmacokinetics and tolerability of an intravenous infusion of the new hydroxyethyl starch 130/0.4 (6%, 500 mL) in mild-to-severe renal impairment.
    Jungheinrich C; Scharpf R; Wargenau M; Bepperling F; Baron JF
    Anesth Analg; 2002 Sep; 95(3):544-51, table of contents. PubMed ID: 12198032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macroamylasaemia after treatment with hydroxyethyl starch.
    Köhler H; Kirch W; Weihrauch TR; Prellwitz W; Horstmann HJ
    Eur J Clin Invest; 1977 Jun; 7(3):205-11. PubMed ID: 70354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid exacerbation of renal function after administration of hydroxyethyl starch in a dog.
    Bae J; Soliman M; Kim H; Kang S; Kim W; Ahn S; Cho K; Choi J; Kim S; Park J; Kim S; DO Y; Yoo J; Yu D
    J Vet Med Sci; 2017 Sep; 79(9):1591-1595. PubMed ID: 28867687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Volume replacement with hydroxyethyl starch: is there an influence on kidney function?].
    Suttner S; Boldt J
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2004 Feb; 39(2):71-7. PubMed ID: 14767795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of hydroxyethyl starch administration on renal function in critically ill patients.
    Sakr Y; Payen D; Reinhart K; Sipmann FS; Zavala E; Bewley J; Marx G; Vincent JL
    Br J Anaesth; 2007 Feb; 98(2):216-24. PubMed ID: 17251213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effect of 6% hydroxyethyl starch 450/0.7, 10% dextran 40 and 3.5% gelatin on plasma volume in patients with terminal renal failure (author's transl)].
    Köhler H; Kirch W; Klein H; Distler A
    Anaesthesist; 1978 Sep; 27(9):421-6. PubMed ID: 82409
    [No Abstract]   [Full Text] [Related]  

  • 15. Intravascular persistence of hydroxyethyl starch in man.
    Boon JC; Jesch F; Ring J; Messmer K
    Eur Surg Res; 1976; 8(6):497-503. PubMed ID: 65282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on low-dose hydroxyethyl starch leukapheresis. Rate of elimination of HES in vivo and function of the harvested granulocytes in vitro.
    Szymanski IO; Teno RA; Gandhi JG; Newburger PE
    Vox Sang; 1984; 47(5):325-9. PubMed ID: 6209854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modern hydroxyethyl starch and acute kidney injury after cardiac surgery: a prospective multicentre cohort.
    Vives M; Callejas R; Duque P; Echarri G; Wijeysundera DN; Hernandez A; Sabate A; Bes-Rastrollo M; Monedero P
    Br J Anaesth; 2016 Oct; 117(4):458-463. PubMed ID: 28077532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydroxyethyl starch (HES) [130/0.4], a new HES specification: pharmacokinetics and safety after multiple infusions of 10% solution in healthy volunteers.
    Waitzinger J; Bepperling F; Pabst G; Opitz J
    Drugs R D; 2003; 4(3):149-57. PubMed ID: 12757400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of high volumes of hydroxyethyl starch with acute kidney injury in elderly trauma patients.
    Leberle R; Ernstberger A; Loibl M; Merkl J; Bunz M; Creutzenberg M; Trabold B
    Injury; 2015 Jan; 46(1):105-9. PubMed ID: 25240412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in the molecular composition of circulating hydroxyethyl starch following consecutive daily infusions in man.
    Mishler JM; Ricketts CR; Parkhouse EJ
    Br J Clin Pharmacol; 1979 May; 7(5):505-9. PubMed ID: 89855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.